You just read:

Kite Pharma's Lead Program with the National Cancer Institute (NCI) Demonstrates Positive Results in Patients with Aggressive Non-Hodgkin's Lymphoma

News provided by

Kite Pharma, Inc.

Dec 07, 2013, 02:24 ET